Danske Bank A S raised its position in Aflac Incorporated (NYSE:AFL – Free Report) by 13.2% during the third quarter, Holdings Channel reports. The institutional investor owned 390,703 shares of the financial services provider’s stock after buying an additional 45,700 shares during the quarter. Danske Bank A S’s holdings in Aflac were worth $43,673,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors also recently made changes to their positions in AFL. BlackRock Inc. bought a new stake in shares of Aflac during the second quarter worth $4,093,787,000. Legal & General Group Plc acquired a new position in shares of Aflac during the second quarter valued at $404,639,000. Bank of New York Mellon Corp acquired a new position in shares of Aflac during the second quarter valued at $298,418,000. Bank of America Corp DE bought a new position in Aflac in the second quarter valued at about $244,516,000. Finally, First Trust Advisors LP boosted its holdings in Aflac by 161.9% in the first quarter. First Trust Advisors LP now owns 3,184,801 shares of the financial services provider’s stock valued at $349,405,000 after acquiring an additional 1,968,738 shares during the last quarter. 67.44% of the stock is owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
A number of brokerages recently commented on AFL. Keefe, Bruyette & Woods lowered their price objective on Aflac from $125.00 to $120.00 and set a “market perform” rating for the company in a research report on Friday, October 9th. JPMorgan Chase & Co. upped their target price on shares of Aflac from $116.00 to $119.00 and gave the company a “neutral” rating in a research report on Thursday, October 15th. Bank of America cut their target price on shares of Aflac from $137.00 to $133.00 and set a “buy” rating on the stock in a research report on Monday, October 12th. Jefferies Financial Group raised their target price on shares of Aflac from $108.00 to $112.00 and gave the company a “hold” rating in a research note on Monday, August 10th. Finally, TD Cowen reiterated a “hold” rating and set a $110.00 price target (up from $101.00) on shares of Aflac in a research report on Wednesday, July 22nd. One analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating, eight have assigned a Hold rating and four have issued a Sell rating to the company. Based on data from MarketBeat, Aflac has an average rating of “Hold” and an average target price of $118.73.
Get Our Latest Analysis on AFL
Key Aflac News
Here’s some of the latest news about AFL:
- Positive Sentiment: Aflac raised its quarterly dividend 4.9%, from $0.61 to $0.64 per share. The new annualized payout is $2.56 per share, or about a 2.0% yield. Aflac dividend announcement
- Neutral Sentiment: Director Joseph Moskowitz sold 600 shares and major shareholder Post Holdings’ Japan entity sold 13,000 shares. Both transactions were made under pre-arranged Rule 10b5-1 plans and were small compared with their remaining holdings.
- Negative Sentiment: Mizuho raised its target to $117 from $112 but retained an “underperform” rating, signaling limited upside in its view. Mizuho forecast update
Aflac Stock Performance
AFL stock opened at $127.44 on Monday. The business’s fifty day moving average is $118.47 and its 200-day moving average is $116.66. The company has a quick ratio of 0.11, a current ratio of 0.11 and a debt-to-equity ratio of 0.30. The company has a market cap of $63.03 billion, a P/E ratio of 18.58, a price-to-earnings-growth ratio of 1.78 and a beta of 0.55. Aflac Incorporated has a twelve month low of $105.76 and a twelve month high of $131.18.
Aflac (NYSE:AFL – Get Free Report) last posted its quarterly earnings results on Wednesday, November 4th. The financial services provider reported $2.43 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.80 by $0.63. Aflac had a return on equity of 12.82% and a net margin of 21.24%. The business had revenue of $4.30 billion for the quarter, compared to analyst estimates of $4.12 billion. During the same period last year, the company earned $2.49 EPS. The firm’s revenue was down 31.0% on a year-over-year basis. Equities research analysts forecast that Aflac Incorporated will post 7.37 EPS for the current year.
Aflac Increases Dividend
The business also recently announced a quarterly dividend, which will be paid on Monday, March 1st. Shareholders of record on Wednesday, February 17th will be paid a $0.64 dividend. The ex-dividend date of this dividend is Wednesday, February 17th. This is a positive change from Aflac’s previous quarterly dividend of $0.61. This represents a $2.56 annualized dividend and a yield of 2.0%. Aflac’s payout ratio is currently 35.57%.
Insiders Place Their Bets
In other Aflac news, major shareholder Post Holdings Co. Ltd. Japan sold 113,611 shares of the stock in a transaction dated Thursday, October 15th. The stock was sold at an average price of $118.53, for a total value of $13,466,311.83. Following the transaction, the insider owned 50,134,329 shares of the company’s stock, valued at approximately $5,942,422,016.37. This represents a 0.23% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 685,662 shares of company stock valued at $80,001,262 over the last quarter. Corporate insiders own 0.80% of the company’s stock.
Aflac Company Profile
Aflac Incorporated is an insurance company that provides supplemental health and life insurance to individuals and businesses. Its products are designed to help customers manage expenses that may not be covered by major medical insurance, including costs associated with accidents, cancer, critical illness and hospital stays. The company operates primarily in the United States and Japan. In the U.S., Aflac offers workplace benefits such as accident, disability, dental, vision and life insurance. In Japan, it provides products including cancer, medical and life insurance.
See Also
- Five stocks we like better than Aflac
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
- Applied Materials Beats and Raises, But Investors Stay Unconvinced
Want to see what other hedge funds are holding AFL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aflac Incorporated (NYSE:AFL – Free Report).
Receive News & Ratings for Aflac Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aflac and related companies with MarketBeat.com's FREE daily email newsletter.
